Avalanche Biotechnologies' IPO

Avalanche Biotechnologies raised a round of funding on July 31, 2014. Investors include Public.

Founded in 2006, Avalanche is a publicly traded (AAVL) biotechnology company that develops technologies and products for sustained delivery of therapeutic proteins to the eye to treat wet age-related …

Articles about Avalanche Biotechnologies' IPO: